Protective effects of selenomethionine against cisplatin-induced renal toxicity in mice and rats

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 6, 1998, Pages 687-691

  Rao, Mahadev ^a   Rao, M N A ^a,b  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Divi's Laboratories Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; CISPLATIN; CREATININE; NITROGEN; SELENOMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FUNCTION; LEUKOCYTE COUNT; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN URINE LEVEL; RAT; SURVIVAL; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0031805764     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06906.x     Document Type: Article

References (25)

1. Badmaev, V., Majeed, M., Passwater, R. A. (1996) Selenium, a quest for better understanding. Altern. Ther. Health Med. 2: 59-67
2. Baldew, G. S., van den Hamer, C. J. A., Los, G., Vermuelen, N. P. E., de Goeij, J. J. M., McVie, J. G. (1989) Selenium induced protection against cis-diaminodichloroplatinum nephrotoxicity in mice and rats. Cancer Res. 49: 3020-3023
3. Berry, J. P., Pauwells, C., Tlouzeau, S., Lespinats, G. (1983) Effect of selenium in combination with cis-diaminedichloroplatium(II) in the treatment of murine fibrosarcoma. Cancer Res. 44: 2854-2868
4. Briviba, K., Roussyn, I., Sharov, V. S., Sies, H. (1996) Attenuation of oxidation and nitration reactions of peroxynitrite by selenomethionine, selenocystine and ebselen. Biochem. J. 319: 13-15
5. Bull, J. M. C., Strebel, F. R., Sunderland, B. A., Bulger, R. E., Edwards, M., Siddik, Z. H., Newman, R. A. (1988) O-(beta-hydroxyethyl)rutoside-mediated protection of renal injury associated with cis-diaminodichloroplatinum/hyperthermia treatment. Cancer Res. 48: 2239-2244
6. Elferink, F., van der Vigh, W. J. F., Klein, I., Pinedo, H. M. (1986) Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin. Chem. 32: 641-645
7. Godkar, P. B. (1994) Kidney function tests. In: Textbook of Medical Laboratory Technology. Bhalani Publishing House, Bombay
8. Goldstein, R. S., Mayor, G. H. (1983) The nephrotoxicity of cisplatin. Life Sci. 32: 685-690
9. Greeder, G. A., Milner, J. A. (1980) Factors influencing the inhibitory effects of selenium on mice inoculated with Ehrlich ascites tumour cells. Science 209: 825-827
10. Har, J. R., Exon, J. H., Whanger, P. D., Weswig, P. H. (1972) Effect of dietary selenium on N-2-fluorenylacetamide (FAA)-induced cancer in vitamin E-supplemented selenium-depleted rats. Clin. Toxicol. 5: 187-194
11. Heidmann, H. T., Gerkens, J. F., Jackson, E. K., Branch, R. A. (1985) Attenuation of cisplatin-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide. Arch. Pharmacol. 329: 201-205
12. Hocman, G. (1988) Chemoprevention of cancer: selenium. Int. J. Biochem. 20: 123-132
13. Howe-Grant, M. E., Lippard, S. J. (1980) Aqueous platinum(II) chemistry. In: Sigel, H. (ed.) Metal Complexes as Anticancer Agents, vol. II. Marcel Dekker, New York, pp 63-125
14. Hu, Y. J., Chen, Y., Zhang, Y. Q., Zhou, M. Z., Song, X. M., Zhang, B. Z., Luo, L., Xu, P. M., Zhao, Y. N., Zhao, Y. B., Cheng, G. (1997) The protective role of selenium on the toxicity of cisplatin-induced chemotherapy regimen in cancer patients. Biol. Trace. Elem. Res. 56: 331-341
15. Inselmann, G., Blohmer, A., Kottny, W., Nellessen, U., Heidemann, H. T. (1995) Modification of cisplatin induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, desferroxamine and torbafylline. Nephron 70: 425-429
16. Madias, N. E., Harringon, J. T. (1978) Platinum nephrotoxicity. Am. J. Med. 65: 307-314
17. McGinness, J. E., Proctor, P. H., Demopaulos, H. B., Hockanson, J. A., Kirkapatrick, D. S. (1978) Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase). Physiol. Chem. Phys. 10: 267-272
18. Milner, J. A. (1985) Effect of selenium on virally induced and transplantable tumour models. Fed. Proc. 44: 2566-2572
19. Milner, J. A., Hsu, C. Y. (1981) Inhibitory effects of selenium on the growth of L1210 leukemia cells. Cancer Res. 41: 1652-1656
20. Nakano, S., Gemba, M. (1989) Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J. Pharmacol. 50: 87-92
21. Rozeneweig, M., van Hoff, D. D., Slavil, M., Muggia, F. M. (1977) cis-Diaminedichloroplatinum, a new anticancer agent. Ann. Int. Med. 86: 803-809
22. Willet, W. C., Morris, J. S., Pressel, S., Taylor, J. O., Polk, B. F., Stampfer, M. J., Rosner, B., Scheider, K., Hames, C. G. (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2: 130-134
23. Zhang, J. G., Lindup, W. E. (1993) Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 45: 2215-2222
24. Zhong, L. F., Zhang, G., Zhang, M., Ma, S. L., Xia, Y. X. (1990) Protection against cisplatin-induced lipid peroxidation and kidney damage by procaine in rats. Arch. Toxicol. 64: 599-600
25. Zwelling, L. A., Kohn, K. W. (1982) Platinum complexes. In: Chabner, B. (ed.) Pharmacologic Principles of Cancer Treatment. W. B. Saunders, Philadelphia, pp 309-339